OAS2 Antikörper (N-Term)
Kurzübersicht für OAS2 Antikörper (N-Term) (ABIN634458)
Target
Alle OAS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- OAS2 antibody was raised against the N terminal of OAS2
-
Aufreinigung
- Affinity purified
-
Immunogen
- OAS2 antibody was raised using the N terminal of OAS2 corresponding to a region with amino acids DEMVNTICDVLQEPEQFPLVQGVAIGGSYGRKTVLRGNSDGTLVLFFSDL
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
OAS2 Blocking Peptide, (ABIN937298), is also available for use as a blocking control in assays to test for specificity of this OAS2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of OAS2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- OAS2 (2'-5'-Oligoadenylate Synthetase 2, 69/71kDa (OAS2))
-
Andere Bezeichnung
- OAS2
-
Hintergrund
- OAS2 is a member of the 2-5A synthetase family, essential proteins involved in the innate immune response to viral infection. It is induced by interferons and uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactions to synthesize 2',5'-oligoadenylates (2-5As). These molecules activate latent RNase L, which results in viral RNA degradation and the inhibition of viral replication.
-
Molekulargewicht
- 79 kDa (MW of target protein)
-
Pathways
- Hepatitis C
Target
-